One February FDA adcomm meeting is delayed, another cancelednews2025-01-28T19:55:13+00:00January 28th, 2025|Endpoints News|
Semaglutide, tirzepatide compounder hit with FDA warning letter news2025-01-28T18:38:28+00:00January 28th, 2025|Endpoints News|
Biopharma execs split on RFK Jr. before confirmation hearingnews2025-01-28T16:00:01+00:00January 28th, 2025|Endpoints News|
Sarepta shares two-year DMD data that may inform Europe decisionnews2025-01-27T20:36:39+00:00January 27th, 2025|Endpoints News|
Trump healthcare transition: Live updates, biotech, pharma newsnews2025-01-27T16:00:12+00:00January 27th, 2025|Endpoints News|
Eisai and Biogen win approval for once-monthly Leqembi dosenews2025-01-27T00:03:18+00:00January 27th, 2025|Endpoints News|
Upcoming PDUFA dates may be ensnared by Trump’s pause at HHS, analyst saysnews2025-01-24T19:45:23+00:00January 24th, 2025|Endpoints News|
Caranx Medical Announces FDA Submission of TAVIPILOT Soft: the World’s first AI Software for Real-time Intra-operative Guidance of Transcatheter Heart Valve Implantationnews2025-01-24T16:57:06+00:00January 24th, 2025|Medical Device News Magazine|
As another Trump term gets underway, pharma advisors get comfortable with uncertaintynews2025-01-23T20:35:28+00:00January 23rd, 2025|Endpoints News|
Teva, Astellas plan to participate in IRA drug price negotiationsnews2025-01-23T20:23:09+00:00January 23rd, 2025|Endpoints News|
